Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001387131-17-003418
Filing Date
2017-06-23
Accepted
2017-06-23 16:47:23
Documents
4
Effectiveness Date
2017-06-23

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT admp-s8_062217.htm S-8 99885
2 OPINION OF WEINTRAUB TOBIN CHEDIAK COLEMAN GRODIN ex5-01.htm EX-5.01 10445
3 CONSENT OF MAYER HOFFMAN MCCANN P.C. ex23-01.htm EX-23.01 2727
4 CONSENT OF HUDSON CISNE & CO. LLP ex23-02.htm EX-23.02 3352
  Complete submission text file 0001387131-17-003418.txt   117533
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-218945 | Film No.: 17928184
SIC: 2834 Pharmaceutical Preparations